Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.

In the Medical Research Council's IVth trial in Myelomatosis the possible benefit of adding vincristine to first line treatment with intermittent melphalan and prednisone has been assessed. This was analysed in 530 patients who were randomly allocated to receive vincristine or not. Survival was...

Descripción completa

Detalles Bibliográficos
Autores principales: MacLennan, I. C., Cusick, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977102/
https://www.ncbi.nlm.nih.gov/pubmed/3896288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977102/
https://www.ncbi.nlm.nih.gov/pubmed/3896288

Ejemplares similares